glp-1 oral solution side effects nausea: How to handle GLP-1s' most common effect GLP-1 Medications: Everything You Need

Researchers looked at 37.1 million adults with type 2 diabetes across this dataset and found a modest increase in the risk of NAION among individuals with [type 2 diabetes] associated with semaglutide use. A study published in June 2025 also connected GLP-1 RAs to neovascular age-related macular degeneration (nAMD)

V., Hertz, C

[21] This impaired signaling may contribute to the formation of hyperexcitable neuronal networks, thereby playing a potential role in seizure development and progression in epilepsy [Figure 1] and [Table 3]

Clinical Evidence: Weight Loss Thresholds and Plantar Fasciitis Symptom Resolution Multiple observational cohorts of patients on GLP-1 therapy report symptom improvement correlating with cumulative weight loss milestones

Congratulations for this great achievement But it was going to be announced on 6th October